The Use of Foxa2-Overexpressing Adipose Tissue-Derived Stem Cells in a Scaffold System Attenuates Acute Liver Injury
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: For the clinical application of stem cell therapy, functional enhancement is needed to increase the survival rate and the engraftment rate. The purpose of this study was to investigate functional enhancement of the paracrine effect using stem cells and hepatocyte-like cells and to minimize stem cell homing by using a scaffold system in a liver disease model. Methods: A microporator was used to overexpress Foxa2 in adipose tissue-derived stem cells (ADSCs), which were cultured in a poly(lactic-co-glycolic acid) (PLGA) scaffold. Later, the ADSCs were cultured in hepatic differentiation medium for 2 weeks by a 3-step method. For in vivo experiments, Foxa2-overexpressing ADSCs were loaded in the scaffold, cultured in hepatic differentiation medium and later were implanted in the dorsa of nude mice subjected to acute liver injury (thioacetamide intraperitoneal injection). Results: Foxa2-overexpressing ADSCs showed greater increases in hepatocyte-specific gene markers (alpha fetoprotein [AFP], cytokeratin 18 [CK18], and albumin), cytoplasmic glycogen storage, and cytochrome P450 expression than cells that underwent the conventional differentiation method. In vivo experiments using the nude mouse model showed that 2 weeks after scaffold implantation, the mRNA expression of AFP, CK18, dipeptidyl peptidase 4 (CD26), and connexin 32 (CX32) was higher in the Foxa2-overexpressing ADSCs group than in the ADSCs group. The Foxa2-overexpressing ADSCs scaffold treatment group showed attenuated liver injury without stem cell homing in the thioacetamideinduced acute liver injury model. Conclusions: Foxa2-overexpressing ADSCs applied in a scaffold system enhanced hepatocyte-like differentiation and attenuated acute liver damage in an acute liver injury model without homing effects.
Abstract
Background/Aims: For the clinical application of stem cell therapy, functional enhancement is needed to increase the survival rate and the engraftment rate. The purpose of this study was to investigate functional enhancement of the paracrine effect using stem cells and hepatocyte-like cells and to minimize stem cell homing by using a scaffold system in a liver disease model. Methods: A microporator was used to overexpress Foxa2 in adipose tissue-derived stem cells (ADSCs), which were cultured in a poly(lactic-co-glycolic acid) (PLGA) scaffold. Later, the ADSCs were cultured in hepatic differentiation medium for 2 weeks by a 3-step method. For in vivo experiments, Foxa2-overexpressing ADSCs were loaded in the scaffold, cultured in hepatic differentiation medium and later were implanted in the dorsa of nude mice subjected to acute liver injury (thioacetamide intraperitoneal injection). Results: Foxa2-overexpressing ADSCs showed greater increases in hepatocyte-specific gene markers (alpha fetoprotein [AFP], cytokeratin 18 [CK18], and albumin), cytoplasmic glycogen storage, and cytochrome P450 expression than cells that underwent the conventional differentiation method. In vivo experiments using the nude mouse model showed that 2 weeks after scaffold implantation, the mRNA expression of AFP, CK18, dipeptidyl peptidase 4 (CD26), and connexin 32 (CX32) was higher in the Foxa2-overexpressing ADSCs group than in the ADSCs group. The Foxa2-overexpressing ADSCs scaffold treatment group showed attenuated liver injury without stem cell homing in the thioacetamideinduced acute liver injury model. Conclusions: Foxa2-overexpressing ADSCs applied in a scaffold system enhanced hepatocyte-like differentiation and attenuated acute liver damage in an acute liver injury model without homing effects.
참고문헌 (25)
- Kern S, "Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue", Stem Cells, 24, pp.1294~1301 (2006)
- Prasajak P, "Developing a new two-step protocol to generate functional hepatocytes from Wharton’s jelly-derived mesenchymal stem cells under hypoxic condition", Stem Cells Int, 2013, pp.762196~ (2013)
- Lee JS, "Electroporation-mediated transfer of Runx2and Osterix genes to enhance osteogenesis of adipose stem cells", Biomaterials, 32, pp.760~768 (2011)
- Lan YW, "Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis", Stem Cell Res Ther, 6, pp.97~ (2015)
- Shams S, "Mesenchymal stem cells pretreated with HGF and FGF4 can reduce liver fibrosis in mice", Stem Cells Int, 2015, pp.747245~ (2015)
- Hu X, "Direct induction of hepatocytelike cells from immortalized human bone marrow mesenchymal stem cells by overexpression of HNF4alpha", Biochem Biophys Res Commun, 478, pp.791~797 (2016)
- Cho JW, "Therapeutic potential of mesenchymal stem cells overexpressing human forkhead box A2 gene in the regeneration of damaged liver tissues", J Gastroenterol Hepatol, 27, pp.1362~1370 (2012)
- 김명덕, "Therapeutic effect of hepatocyte growth factor-secreting mesenchymal stem cells in a rat model of liver fibrosis", Experimental and Molecular Medicine, 46, pp.1~10 (2014), 생화학분자생물학회
- Tang Y, "Therapeutic potential of HGF-expressing human umbilical cord mesenchymal stem cells in mice with acute liver failure", Int J Hepatol, 2016, pp.5452487~ (2016)
- Walesky C, "Role of hepatocyte nuclear factor 4alpha(HNF4alpha)in cell proliferation and cancer", Gene Expr, 16, pp.101~108 (2015)
- Ishii K, "Hepatic differentiation of human bone marrow-derived mesenchymal stem cells by tetracycline-regulated hepatocyte nuclear factor 3beta", Hepatology, 48, pp.597~606 (2008)
- Yamamoto Y, "Recapitulation of in vivo gene expression during hepatic differentiation from murine embryonic stem cells", Hepatology, 42, pp.558~567 (2005)
- Ding Y, "Overexpression of transcription factor Foxa2 and Hnf1alpha induced rat bone mesenchymal stem cells into hepatocytes", Cytotechnology, 68, pp.2037~2047 (2016)
- Jung Y, "Concise review : induced pluripotent stem cell-derived mesenchymal stem cells : progress toward safe clinical products", Stem Cells, 30, pp.42~47 (2012)
- Furlani D, "Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy", Microvasc Res, 77, pp.370~376 (2009)
- Gnecchi M, "Paracrine mechanisms in adult stem cell signaling and therapy", Circ Res, 103, pp.1204~1219 (2008)
- Tang YL, "Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction", Ann Thorac Surg, 80, pp.229~236 (2005)
- Liu T, "Induction of hepatocytelike cells from mouse embryonic stem cells by lentivirusmediated constitutive expression of Foxa2", Hnf4a, 2013, pp.114, 2531~2541
- Iacob R, "Induction of a mature hepatocyte phenotype in adult liver derived progenitor cells by ectopic expression of transcription factors", Stem Cell Res, 6, pp.251~261 (2011)
- Oh SH, "In vitro and in vivo characteristics of PCL scaffolds with pore size gradient fabricated by a centrifugation method", Biomaterials, 28, pp.1664~1671 (2007)
- Oh SH, "Hydrophilized 3D porous scaffold for effective plasmid DNA delivery", J Biomed Mater Res A, 97, pp.441~450 (2011)
- Li J, "3D PLGA scaffolds improve differentiation and function of bone marrow mesenchymal stem cell-derived hepatocytes", Stem Cells Dev, 19, pp.1427~1436 (2010)
- Carrao A, "Mesenchymal stem cells increase neo-angiogenesis and albumin production in a liver tissue-engineered engraftment", Int J Mol Sci, 17, pp.374~ (2016)
- Lee KC, "Extracorporeal liver assist device to exchange albumin and remove endotoxin in acute liver failure : results of a pivotal pre-clinical study", J Hepatol, 63, pp.634~642 (2015)
- Karvellas CJ, "Bench-to-bedside review : current evidence for extracorporeal albumin dialysis systems in liver failure", Crit Care, 11, pp.215~ (2007)